Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03241966 · ClinicalTrials.gov registry record
Perception, Cognition, and Gait in Parkinson's Disease
A clinical trial, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- 439
- Enrollment target
NCT03241966: Completed study, sponsored by Boston University Charles River Campus.
NCT03241966 is a clinical trial that has completed, run by Boston University Charles River Campus. The registered enrollment target is 439 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03241966 has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- 439 participants
- Enrollment target
Study Summary
The investigators are examining how aspects of daily function are perceived in persons with PD and in those who interact with them on a regular basis. If eligible, participants will receive a set of online questionnaires by email. The questionnaires will take about 1 hour to complete, and can be done at the participant's convenience. The investigators are looking for volunteers who have a diagnosis of Parkinson's disease without dementia (age 40 or older and proficient English speakers). If a spouse, family member, significant other or other close associate is available (age 18 or older, proficient English speakers), the investigators will send them questionnaires as well. There is no monetary or other compensation for this study. For more information, please contact the Vision and Cognition Laboratory at vcognition@gmail.com or 617-358-1377.
Primary Outcome
Measures the health status of Parkinson's disease patients and the impact the disease has on their aspects of daily living. There are 39 items.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 439 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2019-01-15 |
What the finished NCT03241966 record still lists
NCT03241966 is an observational study that tracks outcomes without assigning an intervention. The registered 439 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03241966 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03241966 about?
NCT03241966 is a clinical study titled "Perception, Cognition, and Gait in Parkinson's Disease". The investigators are examining how aspects of daily function are perceived in persons with PD and in those who interact with them on a regular basis. If eligible, participants will receive a set of online questionnaires by email. The questionnaires will take about 1 hour to complete, and can be don...
What is the current status of trial NCT03241966?
This trial is currently completed. The enrollment target is 439 participants. The study started on 2017-04-01. Estimated completion is 2019-01-15.
Who is sponsoring clinical trial NCT03241966?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05421663 · 439 participants · Phase 1
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
- NCT06235151 · 439 participants · Phase 3
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer
- NCT05114538 · 440 participants · NA
Improving the Part C Early Intervention Service Delivery System for Children with ASD
- NCT05117619 · 440 participants · NA
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI